The DOI matches its Crossref record; 231 of the 231 references it cites were found in a registry or an index.
Drugging the efferocytosis process: concepts and opportunities
Open accessAbstract
The daily removal of billions of apoptotic cells in the human body via the process of efferocytosis is essential for homeostasis. To allow for this continuous efferocytosis, rapid phenotypic changes occur in the phagocytes enabling them to engulf and digest the apoptotic cargo. In addition, efferocytosis is actively anti-inflammatory and promotes resolution. Owing to its ubiquitous nature and the sheer volume of cell turnover, efferocytosis is a point of vulnerability. Aberrations in efferocytosis are associated with numerous inflammatory pathologies, including atherosclerosis, cancer and infections. The recent exciting discoveries defining the molecular machinery involved in efferocytosis have opened many avenues for therapeutic intervention, with several agents now in clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“efferocytosis in other settings can promote fibrosis as part of the tissue resolution process, for example, by secreting TGF-β1 (12, 13).”
From Impaired TIM4-mediated efferocytosis by liver macrophages contributes to fibrosis in metabolic dysfunction–associated steatohepatitis (2025) · cites this paper as [13]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While some progress has been made with respect to the Fractalkine receptor (CX3C motif chemokine receptor 1), Axl, MerTK, CD47 and Tim4/3, no approaches have thus far been clinically approved (64).”
From Cholesterol efflux protein, ABCA1, supports anticancer functions of myeloid immune cells (2026) · cites this paper as [64]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The accumulation of dead cells in disease settings indicates impaired clearance of dead cells by macrophages (“efferocytosis”) (12, 13).”
From Impaired TIM4-mediated efferocytosis by liver macrophages contributes to fibrosis in metabolic dysfunction–associated steatohepatitis (2025) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“Efferocytosis not only prevents dead cell accumulation but also reprograms macrophages to execute tissue resolution functions, and impaired efferocytosis contributes to many human chronic inflammatory diseases (12, 13).”
From Impaired TIM4-mediated efferocytosis by liver macrophages contributes to fibrosis in metabolic dysfunction–associated steatohepatitis (2025) · cites this paper as [13]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“It is seen as a major hurdle to using antigen presenting cells in cell-based therapies (61–64).”
From Cholesterol efflux protein, ABCA1, supports anticancer functions of myeloid immune cells (2026) · cites this paper as [64]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Tan, X., Zhang, Z., Yao, H., & Shen, L. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.08.012 · Cited by 76
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease
Cappello, V., Marchetti, L., Parlanti, P., Landi, S., Tonazzini, I., Cecchini, M., Piazza, V., & Gemmi, M. (2016) · Scientific Reports · doi:10.1038/s41598-016-0001-8 · Cited by 13,097
The trinity of COVID-19: immunity, inflammation and intervention
Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. P. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0311-8 · Cited by 4,360
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1256 · Cited by 3,414
Fadok, V. A., Voelker, D. R., Campbell, P. A., Cohen, J., Bratton, D. L., & Henson, P. M. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.7.2207 · Cited by 3,321
Immunogenic Cell Death in Cancer Therapy
Kroemer, G., Galluzzi, L., Kepp, O., & Zitvogel, L. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100008 · Cited by 3,303
Immunogenic cell death in cancer and infectious disease
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.107 · Cited by 3,119
Research works printed but not linked: 4
- Urbani, L. et al. in Transplantation Proceedings 1175–1178 (Elsevier, 2004).
- Dalli, J., Colas, R., Shinohara, M. & Serhan, C. N. Aging delays resolution of acute inflammation in mice: reprogramming the host response with novel nano-proresolving. Medicines 193, 4235–4244 (2014).
- Noelia, A. et al. Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity 31, 245–258 (2009). This important study highlights the role of nuclear receptors in anti-inflammatory effects of efferocytosis and plausible therapeutic advantages of targeting the pathway. · DOI
- Bohan, D. et al. Targeting the receptor AXL by bemcentinib prevents SARS-CoV-2 infection. Top. Antivir. Med. 29, 137–138 (2021).
Cited by
Sorted by citations
Items 201–300 of 475
Proinflammatory cytokines sensitise mesenchymal stromal cells to apoptosis
Payne, N. L., Pang, S. H. M., Freeman, A. J., Ozkocak, D. C., Limar, J. W., Wallis, G., Zheng, D., Mendonca, S., O’Reilly, L. A., Gray, D. H. D., et al. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02412-0 · Cited by 7
Chen, W., Zeng, S., Zhong, J., Zou, J., Lei, Y., Chen, X., Mei, Q., & Luo, Q. (2025) · Discover Oncology · doi:10.1007/s12672-025-02419-0 · Cited by 7
Millar, B., & de Gaetano, M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1125858 · Cited by 7
The Role of Macrophages in Atherosclerosis: Participants and Therapists
Liu, X., Pang, S., Jiang, Y., Wang, L., & Liu, Y. (2023) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-023-07513-5 · Cited by 7
Yu, W., Yao, D., Ma, X., Hou, J., & Tian, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-04037-w · Cited by 7
Stress granule assembly impairs macrophage efferocytosis to aggravate allergic rhinitis in mice
Zhou, Y., Yang, Z., Wang, Y., Dong, Y., Wang, T., Li, Y., Liang, C., Liu, Y., Li, Z., Liu, S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60920-0 · Cited by 6
ALDH2 in autophagy and cell death: molecular mechanisms and implications for diseases
Duan, Y., Shan, Z.-C., Pang, J., & Chen, Y. (2025) · Military Medical Research · doi:10.1186/s40779-025-00646-8 · Cited by 6
Ji, W., Shao, W., Ye, X., Kankala, R. K., Chen, A., & Zhang, X. (2025) · Small · doi:10.1002/smll.202506957 · Cited by 6
Macrophage polarization in tumors: The impact of efferocytosis
Zhang, Y., Zang, H., & Wen, Q. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115807 · Cited by 6
Li, W., Ying, F., Pang, X., Wu, Q., Li, G., Huang, L., Xin, J., Liu, X., Liu, P., Xu, X., et al. (2025) · Advanced Science · doi:10.1002/advs.202512508 · Cited by 6
Lu, Y., Wan, X., Ye, H., Wu, Y., Zhang, Y., Cheng, M., Zhu, X., Cao, Y., Wang, J., Zhang, Q., et al. (2025) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.66.15.22 · Cited by 6
Luo, Y., Huang, Y., Huang, Y., & Chen, L. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07485-0 · Cited by 6
The Role of TREM2 After Stroke: From Mechanisms to Therapeutic Potential
Zhou, T., Chen, A., Sun, Y., Huang, B., Xu, Y., & He, Q. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05622-w · Cited by 6
Injectable hybrid hydrogels enhance macrophage communication via second messenger amplification
Du, Y., Huang, F., Chen, H., Ling, S., Wang, H., Zhuang, Y., Wu, T., Yang, K., Jin, W., & Cui, W. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114610 · Cited by 6
Chen, Y., Lin, H., Wang, J., Li, F., AMOURI, R. E., Ip, J. C., Liu, W., & Mo, J. (2026) · New Contaminants · doi:10.48130/newcontam-0025-0022 · Cited by 6
Potential roles for efferocytosis in glioblastoma immune evasion
Lorimer, I. A. J. (2024) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdae012 · Cited by 6
Osteogenesis imperfecta type 10 and the cellular scaffolds underlying common immunological diseases
Herbert, A. G. (2024) · Genes and Immunity · doi:10.1038/s41435-024-00277-4 · Cited by 6
Li, L., Gu, W., Yuan, X., Fan, W., Zhang, L., Qu, Z., Zhao, F., & Yin, H. (2025) · The FASEB Journal · doi:10.1096/fj.202501079r · Cited by 6
Apoptosis and Cell Clearance in Skin Wound Healing
Cleene, H. K. L. D., Keçeli, B. N., & Maschalidi, S. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-92785-0_5 · Cited by 6
Kang, Y., Jin, Q. K., Zhou, M., Zheng, H., Li, D. R., Wang, X., Zhou, J., Lv, J., & Wang, Y. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1652402 · Cited by 6
Tu, M., Zou, X., Tan, X., Liu, Y., Ge, X., Hu, Y., Peng, Q., Huang, L., Zeng, Y., Jia, C., et al. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0579 · Cited by 6
Role of efferocytosis in chronic pain —— From molecular perspective
Zang, H., Ji, X., Yao, W., Wan, L., Zhang, C., Zhu, C., & Liu, T. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106857 · Cited by 6
Zhou, J., & Gao, T. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1538867 · Cited by 6
Fernandes, D. D. O., Machado, J. R., Beltrami, V. A., dos Santos, A. C. P. M., Queiroz‐Junior, C. M., Vago, J. P., Soriani, F. M., Amaral, F. A., Teixeira, M. M., Félix, F. B., et al. (2024) · British Journal of Pharmacology · doi:10.1111/bph.17375 · Cited by 5
Shi, B., Tang, C., Rutter, S. F., Audi, O., Ozkocak, D. C., Trenerry, A. M., Simpson, D. S., Williams, S. A., Le, Q. T., Ryan, G. F., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1599809 · Cited by 5
Jiang, K., Luan, Y., Shen, N., Qi, X., Hu, L., Wang, Y., Liu, W., Wang, R., Lin, T., & Peng, D. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70538 · Cited by 5
Prince, A., Traughber, C. A., Shiravand, Y., Bhandari, N., Khan, M. R., Sharma, S., Timinski, K., Murray, K. F., Bull, L. N., & Gulshan, K. (2025) · Cell Cycle · doi:10.1080/15384101.2025.2574275 · Cited by 5
Su, Y., Wang, H., Liu, H., & Tang, Y. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115899 · Cited by 5
Wang, Z., Chen, X., Xu, Y., Guo, X., Liu, X., Dai, X., Lü, J., Qi, J., Zheng, T., Zhang, L., et al. (2025) · ACS Nano · doi:10.1021/acsnano.5c17402 · Cited by 5
Liu, X., Feng, G., Yuan, P., Zhang, Z., & Kong, L. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.173072 · Cited by 5
Cell death in sepsis: unveiling new perspectives on organ dysfunction
Jiang, R., & Cai, P. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1823003 · Cited by 5
Zhang, C., Deng, J., Li, K., Lai, G., Liu, H., Zhang, Y., Xie, B., & Zhong, X. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05512-5 · Cited by 5
We are what we eat: macrophages and efferocytosis
Cunningham, K. T., & Maizels, R. M. (2024) · Trends in Parasitology · doi:10.1016/j.pt.2024.05.004 · Cited by 5
Lu, Q. L., Chen, X., & Zhang, Q. (2024) · Tissue and Cell · doi:10.1016/j.tice.2024.102476 · Cited by 5
Could Gas6/TAM Axis Provide Valuable Insights into the Pathogenesis of Systemic Sclerosis?
Apostolo, D., D’Onghia, D., Nerviani, A., Ghirardi, G. M., Sola, D., Perazzi, M., Tonello, S., Colangelo, D., Sainaghi, P. P., & Bellan, M. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46070444 · Cited by 5
Immunomodulatory effect of efferocytosis at the maternal–fetal interface
Tao, H., Ma, R., Cui, J., Yang, Z., He, W., Li, Y., & Zhao, Y. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02055-9 · Cited by 5
Hunter, C. R., & Hudson, J. E. (2025) · Current Cardiology Reports · doi:10.1007/s11886-025-02246-3 · Cited by 5
Ha, K. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01083-0 · Cited by 5
Kojima, Y., Ye, Z., Wang, F., Lotfi, M., Bell, C., Adkar, S. S., Luo, L., Fu, C., & Leeper, N. J. (2025) · Science Signaling · doi:10.1126/scisignal.ads6584 · Cited by 4
Li, M., Dong, W., Cui, Y., Li, J., Yang, C., Zhang, D., & Fu, X. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102233 · Cited by 4
Irgm1 Improves Postinfarction Cardiac Repair by Promoting Neutrophil Clearance and Efferocytosis
Wang, Z., Wei, L., Wang, M., Wang, S., Xiu, L., Sun, J., Lu, R., Liu, Y., Wang, J., Liu, F., et al. (2026) · Advanced Science · doi:10.1002/advs.202514863 · Cited by 4
Apoptotic Bodies in Kidney Disease
Cozzolino, M. G., & Ciceri, P. (2026) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000001073 · Cited by 4
Programmed cell death in lung cancer: mechanisms, immune responses, and therapeutics
Liu, Y., Chen, Q., Xu, J., & Chi, H. (2026) · APOPTOSIS · doi:10.1007/s10495-026-02298-y · Cited by 4
Comparative insights into the apoptosome, inflammasomes and PIDDosome
Lamkanfi, M., Walle, L. V., Eichin, F., & Villunger, A. (2026) · Nature reviews. Immunology · doi:10.1038/s41577-026-01304-3 · Cited by 4
Balaban, R., Moskowitz, O., Levinson, M., Ofer, N., Raizman, A., Kitron, G. L., Aviv, E., Camargo, S., Goldman, L., Leemann, A., et al. (2026) · Science Immunology · doi:10.1126/sciimmunol.aed1544 · Cited by 4
Interferons: Invited guests at the brain’s gala banquet
Márquez-Ropero, M., & Sierra, A. (2024) · Neuron · doi:10.1016/j.neuron.2024.03.010 · Cited by 4
Consequence of alcohol intoxication-mediated efferocytosis impairment
Brahadeeswaran, S., & Tamizhselvi, R. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1386658 · Cited by 4
Zhang, W., Zhang, S., Knoedler, S. A., Han, W., Zha, K., Li, H., Panayi, A. C., Alfertshofer, M. G., Kim, B., Hu, W., et al. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.154800 · Cited by 5
Efferocytosis: A new star of atherosclerotic plaques reversal
Liang, X., Tian, S., Zhang, H., Sun, S., Zhang, P., Li, J., Liu, Z., Zhang, Y., & Liu, Z. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113904 · Cited by 4
Song, J., Yuan, C., Wang, F., Lei, D., Tian, X., Yang, L., Li, Z., Yi, X., Chen, S., Zeng, Y., et al. (2025) · Chinese Medicine · doi:10.1186/s13020-025-01208-9 · Cited by 4
Hong, J., Wang, W., Hsu, Y., Tee, S. Y., Wu, Y., Huang, W., Lai, S., & Lin, S. (2023) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2023.07.012 · Cited by 4
Phagocytic clearance of dying cells and its implications
Ravichandran, K. S. (2023) · Immunological Reviews · doi:10.1111/imr.13285 · Cited by 4
Self-citationPan, Q., Chen, C., & Yang, Y. (2023) · Current Medical Science · doi:10.1007/s11596-023-2818-2 · Cited by 4
Xu, W., Han, L., Zhu, P., Cheng, Y., & Chen, X. (2023) · Aging · doi:10.18632/aging.205422 · Cited by 4
Armero, M., Smolkin, M., García‐Domínguez, M., Berraondo, P., Melero, I., & Gálvez‐Cancino, F. (2025) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-25-0434 · Cited by 3
Wang, J., Li, Z., Wang, Z., Liang, W., Meng, S., Chen, J.-F., Wang, J., Zhang, J., & Lin, B. (2025) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szaf058 · Cited by 3
Extracellular matrices regulate extravasation journey of leukocytes and inflammatory tissue fate
Li, Y. (2025) · eLife · doi:10.7554/elife.108284.3 · Cited by 3
Gaudet, A. D., & Fonken, L. K. (2026) · Trends in Neurosciences · doi:10.1016/j.tins.2026.01.002 · Cited by 3
Wang, X. T., Liu, Y., Nie, T., Tang, Z., Tao, J., Wang, Q., Ma, X., Chu, W., Li, Z., Zhu, C., et al. (2026) · Bioactive Materials · doi:10.1016/j.bioactmat.2026.03.025 · Cited by 3
Yu, C., Feng, Q., Liao, Y., Tan, M., Zhao, Y., Chen, L., Zhang, W., Lin, C., Zeng, R., Al-Smadi, F., et al. (2026) · Bioactive Materials · doi:10.1016/j.bioactmat.2026.04.009 · Cited by 3
Jin, C., Shen, D., Zhuang, Z., zhang, Q., Wu, Y., Hu, Z., Zhang, K., Li, L., Gu, Z., Hu, Y., et al. (2026) · Cell Biomaterials · doi:10.1016/j.celbio.2026.100447 · Cited by 3
Tan, J., Yang, D., Qin, L., Chen, Z., Xu, Z., Wei, C., Chen, J., Huang, Y., Yang, D., Fang, Y., et al. (2026) · Bioactive Materials · doi:10.1016/j.bioactmat.2026.05.020 · Cited by 3
Wang, L., Ge, J., Wang, Z., Wang, W., Hong, Q., Fang, Y., Xu, J., Han, H., & Qin, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-99133-2 · Cited by 3
Engineering a macromolecular JAK inhibitor for treating acute inflammation and endotoxaemia
Zhou, M., Wang, Y., Yang, B., Zhang, Y., Zhong, L., Hu, K., Pu, W., Luo, G., & Zhang, J. (2025) · Nature Biomedical Engineering · doi:10.1038/s41551-025-01521-6 · Cited by 3
A bibliometric analysis of efferocytosis in cardiovascular diseases from 2001 to 2022
Hu, L., Lv, Z., Gu, Y., Zheng, T., Kong, Y., & Mao, W. (2023) · Medicine · doi:10.1097/md.0000000000034366 · Cited by 3
Non-viral vector-based genome editing for cancer immunotherapy
Fang, T., & Chen, G. (2024) · Biomaterials Science · doi:10.1039/d4bm00286e · Cited by 3
Tang, J. Y., Lü, B., Bin, T., Xu, X., Lin, C., Wang, Y., & Xie, W. (2024) · Annals of Medicine · doi:10.1080/07853890.2024.2425065 · Cited by 3
Zhou, X., He, J., Song, H., Zhao, W., Li, R., Han, W., & Li, Q. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.03.003 · Cited by 3
Li, H., Zhang, J., Zhang, Y., Li, Z., Han, Y., & Lun, Y. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70671 · Cited by 3
Host Cell Death Signaling Pathways Manipulated by Mycobacterium tuberculosisPreprint
Ding, G., & Briken, V. (2026) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041824 · Cited by 4
Beltrán‐Visiedo, M., del Valle, A. S., Jiménez‐Alduán, N., Soler-Agesta, R., Naval, J., Galluzzi, L., & Marzo, I. (2024) · Methods in cell biology · doi:10.1016/bs.mcb.2024.05.009 · Cited by 2
Optimized network inference for immune diseased single cells
Tejero, E. M., Vaz, D. J., Barturen, G., Rivas-Torrubia, M., Alarcón-Riquelme, M. E., Kölch, W., & Matallanas, D. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1597862 · Cited by 2
Liu, B., Zu, T., Lu, Y.-H., Xing, C., Gao, M., Wu, F., & Jiang, M. (2025) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2025.102161 · Cited by 2
Breitenstein, P., Martin, M., Visser, V. L., Motta, S. E., Emmert, M. Y., Generali, M., & Hoerstrup, S. P. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123765 · Cited by 2
Efferocytosis: a therapeutic strategy for diabetes and its vascular complications
Song, Y., Yuan, J., Li, Y., Liu, Y., & Qin, G. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1641748 · Cited by 2
Zhang, W., Chen, Q., Li, Y., Zhang, L., Wang, M., Sun, B., Yang, S., Yang, F., & Dong, H. (2025) · European journal of medical research · doi:10.1186/s40001-025-03622-z · Cited by 3
Yang, Y., Chen, T., Xu, Z., Cai, J., Wang, W., Pan, L., Cheng, X., & Wang, A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1737749 · Cited by 2
Wang, H., Hu, H., Li, Y., Hu, L., Gu, C., Zhu, Y. T., Huang, J., Li, N., Jiang, S., Zu, S., et al. (2025) · Advanced Science · doi:10.1002/advs.202513474 · Cited by 2
Omentin-1 promotes diabetic wound healing by regulating macrophage efferocytosis and M2 polarization
Huang, Y., Ding, X., Dong, Z. F., Ding, Y., Chen, Y., Zou, H., Chen, J., Yang, P., Chen, T., Ma, Z., et al. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.150757 · Cited by 2
Ling, J., Wang, D., Li, J., Liang, J., Hu, Q., Zhang, Q., Zheng, Y., Lin, B., & Lin, X. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116410 · Cited by 2
He, Y., Ye, K., Zhang, Y., Chen, Z., Sun, H., Cui, G., Ghanad, P., Mao, Z., Huang, Y., Ren, Z., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-69540-8 · Cited by 2
Exclusion of Notch from the contact site during efferocytosis restricts anticancer immunity
Li, Z., Xu, B., Sharma, P., Guy, C. S., Boada-Romero, E., Verbist, K., Guo, A., Mari, L., Poudel, S., Yang, M., et al. (2026) · Nature Immunology · doi:10.1038/s41590-026-02452-3 · Cited by 2
Fan, P., Ruan, Y., Kaichao, H. U., Wang, H., Ye, J.-R., Wang, S., Yuan, R., Yang, G., Liu, F., He, W., et al. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.04.003 · Cited by 2
Su, T.-H., Cao, J., Ding, X.-X., Guo, X.-Z., Chen, A.-L., Zhou, W.-H., Deng, P., Luo, P., Chen, Y., & Wang, F. (2026) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c17222 · Cited by 2
ELMO1 dependent efferocytosis protects from nephrotoxin induced acute kidney injury
Baffert, B., Cholko, M., Sabapathy, V., Modhukuru, P., Heath, I., Zheng, S., GAUTAM, J., Schneider, K., Silverman, L., Okusa, M., et al. (2026) · Cell Death Discovery · doi:10.1038/s41420-026-03140-9 · Cited by 2
Ma, X. Y., Lin, R., Xu, Y., Ye, Y., Qiu, J., Wang, H., Hu, W. W., Zhou, W., Zhang, T., Yang, G., et al. (2026) · ACS Nano · doi:10.1021/acsnano.6c01427 · Cited by 2
Zhou, C., Gan, X., Sun, S., Wang, L., Zhang, Y., & Zhang, J. (2023) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2023.101540 · Cited by 2
Chen, P., Li, Z., & Li, N. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e30337 · Cited by 2
Kanuri, S. H. (2024) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-024-00853-5 · Cited by 2
Therapeutic implication of targeting mitochondrial drugs designed for efferocytosis dysfunction
Liu, W.-T., Li, C.-Q., Fu, A.-N., Yang, H., Xie, Y., Yao, H., & Yi, G. (2024) · Journal of drug targeting · doi:10.1080/1061186x.2024.2386620 · Cited by 2
Rodríguez-Iglesias, N., Paris, I., Valero, J., Cañas‐Zabala, L., Carretero, A., Hatje, K., Zhang, J. D., Patsch, C., Britschgi, M., Gutbier, S., et al. (2024) · Glia · doi:10.1002/glia.24637 · Cited by 2
Role of Apoptosis in Cancer: War of the Worlds, Therapeutic Targets and Strategies
Dhara, A., Kaur, R., Chattopadhyay, R., Das, S., Pal, S., & Sen, N. (2024) · Springer eBooks · doi:10.1007/978-981-97-7905-5_9 · Cited by 2
FANG, C., Li, Y., Ling, G., ZHENG, B., Luo, C., Jiang, J., Jia, B., & Wang, C. (2025) · Biocell · doi:10.32604/biocell.2024.056981 · Cited by 2
12/15-Lipoxygenase-Derived Electrophilic Lipid Modifications in Phagocytic Macrophages
Deng, K., Isobe, Y., Tsumagari, K., Kato, T., Arai, H., Imami, K., & Arita, M. (2025) · ACS Chemical Biology · doi:10.1021/acschembio.4c00624 · Cited by 2
You, M., Li, J., Wang, X., Liu, Y., Chen, S., & Wang, P. (2025) · Inflammation · doi:10.1007/s10753-025-02312-6 · Cited by 2
Ma, L., Zhao, L., Zhang, Y., Ma, Y., Shang, Q., & Liu, X. (2025) · Discover Oncology · doi:10.1007/s12672-025-02901-9 · Cited by 2
Mapping the evolving trend of research on efferocytosis: a comprehensive data-mining-based study
Jian, Y., Dong, S., Liu, W., Li, G., Lian, X., & Wang, Y. (2025) · BioData Mining · doi:10.1186/s13040-025-00475-4 · Cited by 2
Impaired Efferocytosis of Pericytes and Vascular Smooth Muscle Cells in Diabetic Retinopathy
Gardiner, T. A., Little, K., & Stitt, A. W. (2025) · Cells · doi:10.3390/cells14171349 · Cited by 2
You are what you eat and how you digest it! A discussion on inflammatory efferocytosis
Tanzer, M. C. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1132696 · Cited by 2
Construction and validation of an efferocytosis-related prognostic signature in lung adenocarcinoma
Liu, J., & Li, W. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05251-7 · Cited by 2
Metadata
- Authors
- Mehrotra, P., & Ravichandran, K. S.
- Affiliations
- VIB-UGent Center for Inflammation Research (BE)
- Washington University in St. Louis (US)
- Corresponding author
- Ravichandran, Kodi S.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2022-06-01
- Volume
- 21
- Issue
- 8
- Pages
- 601-620
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- PMC
- PMC9157040
- OpenAlex
- W4281737563
- Cited by
- 459
- References
- 231
- Citations by year
- 2026: 130 · 2025: 153 · 2024: 104 · 2023: 66 · 2022: 6
- FWCI
- 8.88
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P01HL120840)
- National Institute of General Medical Sciences (R35GM122542)
- National Institute of Allergy and Infectious Diseases (R01AI159551)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- efferocytosis, phagocytes, anti-inflammatory mechanism, inflammation resolution, therapeutic target, atherosclerosis, cancer, infection
- MeSH terms
- Homeostasis, Humans, Phagocytes, Phagocytosis, Apoptosis, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
